These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38514542)

  • 1. [Important: Pneumococcal protection for older people].
    Heppner HJ
    MMW Fortschr Med; 2024 Mar; 166(5):22-25. PubMed ID: 38514542
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan.
    Nakashima K; Suzuki K; Aoshima M; Murabata M; Kondo K; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
    Vaccine; 2022 Nov; 40(46):6589-6598. PubMed ID: 36184405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
    Gessner BD; Jiang Q; Van Werkhoven CH; Sings HL; Webber C; Scott D; Gruber WC; Grobbee DE; Bonten MJM; Jodar L
    Vaccine; 2019 Jul; 37(30):4147-4154. PubMed ID: 31155413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
    Sings HL
    Vaccine; 2017 Sep; 35(40):5406-5417. PubMed ID: 28602602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia.
    van Werkhoven CH; Huijts SM
    Clin Chest Med; 2018 Dec; 39(4):733-752. PubMed ID: 30390745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.
    Isturiz RE; Hall-Murray C; McLaughlin JM; Snow V; Schmoele-Thoma B; Webber C; Thompson A; Scott DA
    Expert Rev Vaccines; 2018 Jan; 17(1):45-55. PubMed ID: 29183235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil.
    Duarte FG; Barberino MG; da Silva Moreira S; Reis JN; Spinardi JR; de Almeida RS; Allen KE; Alexander-Parrish R; Brim R; de Araújo Neto CA; Moreira ED
    BMJ Open; 2022 Apr; 12(4):e059824. PubMed ID: 35428648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.
    Plosker GL
    Drugs; 2015 Sep; 75(13):1535-46. PubMed ID: 26242768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Pneumococcal Vaccination Against Pneumococcal Pneumonia Hospitalization in Older Adults: A Prospective, Test-Negative Study.
    Heo JY; Seo YB; Choi WS; Kim EJ; Jeong HW; Lee J; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Song JY
    J Infect Dis; 2022 Mar; 225(5):836-845. PubMed ID: 34537847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 - April 2019.
    Liapikou A; Konstantinidis A; Kossyvaki V; Skiadas J; Menegas D; Méndez C; Beavon R; Begier E; Gessner BD; Milionis H; Tsimihodimos V; Baxevanos G; Argiriadou T; Terrovitou C; Toumbis M;
    Hum Vaccin Immunother; 2022 Nov; 18(5):2079923. PubMed ID: 35703733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.
    Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM
    J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal conjugate vaccine use in adults.
    Isturiz RE; Schmoele-Thoma B; Scott DA; Jodar L; Webber C; Sings HL; Paradiso P
    Expert Rev Vaccines; 2016; 15(3):279-93. PubMed ID: 26651847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults.
    Isturiz R; Webber C
    Hum Vaccin Immunother; 2015; 11(7):1825-7. PubMed ID: 26076136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
    van Werkhoven CH
    Hum Vaccin Immunother; 2017 May; 13(5):1177-1181. PubMed ID: 27937061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine.
    De Wals P; Desjardins M
    Vaccine; 2024 Apr; 42(12):2933-2936. PubMed ID: 38346915
    [No Abstract]   [Full Text] [Related]  

  • 18. In brief: PCV13 for adults 65 years and older.
    Med Lett Drugs Ther; 2014 Oct; 56(1453):102. PubMed ID: 25296261
    [No Abstract]   [Full Text] [Related]  

  • 19. Theory and strategy for Pneumococcal vaccines in the elderly.
    Namkoong H; Ishii M; Funatsu Y; Kimizuka Y; Yagi K; Asami T; Asakura T; Suzuki S; Kamo T; Fujiwara H; Tasaka S; Betsuyaku T; Hasegawa N
    Hum Vaccin Immunother; 2016; 12(2):336-43. PubMed ID: 26406267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
    Ludwig E; Mészner Z;
    Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.